Document is current
Any future updates will be listed below
-
Authors
Shi, Yuankai
Han, Xiaohong
Zhao, Qian
Zheng, YuLong
Chen, Jianhua
Yu, Xinmin
Fang, Jian
Liu, Yutao
Huang, Dingzhi
Liu, Tianshu
Shen, Hong
Luo, Suxia
Yu, Hongsheng
Cao, Yu
Zhang, Xi
Hu, Pei
-
Funding
Funding for this research was provided by:
China National Major Project for New Drug Innovation (2017ZX09304015, 2019ZX09201-002)
Shanghai Kechow Pharma, Inc., Shanghai, the People’s Republic of China
- License Information
-
More Information
Article History
Received: 16 November 2023
Accepted: 3 June 2024
First Online: 12 June 2024
Declarations
:
: The study was approved by the ethics committees of each trial site. The trial was registered on clinicaltrials.gov (NCT03781219).
: All patients provided written informed consent prior to enrolment.
: Previously, part of the results of this study have been presented as a poster (poster No.3973) at the 2023 European Society for Medical Oncology Congress, Madrid, Spain, October 20–24, 2023.
: The authors declare no competing interests.
